# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-24-002889
Filing Date
2024-01-05
Accepted
2024-01-05 08:00:59
Documents
45
Period of Report
2024-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d704842d8k.htm iXBRL | 8-K | 25740
2 | EX-99.1 | d704842dex991.htm | EX-99.1 | 37805
6 | GRAPHIC | g704842ex99_1p10g1.jpg | GRAPHIC | 358675
7 | GRAPHIC | g704842ex99_1p11g1.jpg | GRAPHIC | 420525
8 | GRAPHIC | g704842ex99_1p12g1.jpg | GRAPHIC | 331888
9 | GRAPHIC | g704842ex99_1p13g1.jpg | GRAPHIC | 340640
10 | GRAPHIC | g704842ex99_1p14g1.jpg | GRAPHIC | 331194
11 | GRAPHIC | g704842ex99_1p15g1.jpg | GRAPHIC | 250405
12 | GRAPHIC | g704842ex99_1p16g1.jpg | GRAPHIC | 235616
13 | GRAPHIC | g704842ex99_1p17g1.jpg | GRAPHIC | 306768
14 | GRAPHIC | g704842ex99_1p18g1.jpg | GRAPHIC | 330827
15 | GRAPHIC | g704842ex99_1p19g1.jpg | GRAPHIC | 268794
16 | GRAPHIC | g704842ex99_1p1g1.jpg | GRAPHIC | 286499
17 | GRAPHIC | g704842ex99_1p20g1.jpg | GRAPHIC | 287315
18 | GRAPHIC | g704842ex99_1p21g1.jpg | GRAPHIC | 396461
19 | GRAPHIC | g704842ex99_1p22g1.jpg | GRAPHIC | 370208
20 | GRAPHIC | g704842ex99_1p23g1.jpg | GRAPHIC | 332098
21 | GRAPHIC | g704842ex99_1p24g1.jpg | GRAPHIC | 304412
22 | GRAPHIC | g704842ex99_1p25g1.jpg | GRAPHIC | 387077
23 | GRAPHIC | g704842ex99_1p26g1.jpg | GRAPHIC | 311928
24 | GRAPHIC | g704842ex99_1p27g1.jpg | GRAPHIC | 449163
25 | GRAPHIC | g704842ex99_1p28g1.jpg | GRAPHIC | 328124
26 | GRAPHIC | g704842ex99_1p29g1.jpg | GRAPHIC | 289558
27 | GRAPHIC | g704842ex99_1p2g1.jpg | GRAPHIC | 605703
28 | GRAPHIC | g704842ex99_1p30g1.jpg | GRAPHIC | 216032
29 | GRAPHIC | g704842ex99_1p31g1.jpg | GRAPHIC | 339196
30 | GRAPHIC | g704842ex99_1p32g1.jpg | GRAPHIC | 207806
31 | GRAPHIC | g704842ex99_1p3g1.jpg | GRAPHIC | 143785
32 | GRAPHIC | g704842ex99_1p4g1.jpg | GRAPHIC | 339008
33 | GRAPHIC | g704842ex99_1p5g1.jpg | GRAPHIC | 287555
34 | GRAPHIC | g704842ex99_1p6g1.jpg | GRAPHIC | 329659
35 | GRAPHIC | g704842ex99_1p7g1.jpg | GRAPHIC | 356901
36 | GRAPHIC | g704842ex99_1p8g1.jpg | GRAPHIC | 314855
37 | GRAPHIC | g704842ex99_1p9g1.jpg | GRAPHIC | 382545
| Complete submission text file | 0001193125-24-002889.txt |  | 14585014

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | svra-20240105.xsd | EX-101.SCH | 2864
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | svra-20240105_lab.xml | EX-101.LAB | 17993
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | svra-20240105_pre.xml | EX-101.PRE | 11270
39 | EXTRACTED XBRL INSTANCE DOCUMENT | d704842d8k_htm.xml | XML | 3397

Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 24514469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)